POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM

2004 ◽  
Vol 10 ◽  
pp. 48-60 ◽  
Author(s):  
Brian Patrick O'Neill ◽  
David Schiff
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Lymphoproliferative Disorders ◽  
Post Transplant ◽  
The Central Nervous System

scholarly journals Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Matthew L. White ◽  
Drew W. Moore ◽  
Yan Zhang ◽  
Keiper D. Mark ◽  
Timothy C. Greiner ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Lymphoproliferative Disorders ◽  
Post Transplant

Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system

2008 ◽  
Vol 50 (4) ◽  
pp. 886-888 ◽  
Author(s):  
Gretha van de Glind ◽  
Siebold de Graaf ◽  
Christoph Klein ◽  
Marlies Cornelissen ◽  
Britta Maecker ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Lymphoproliferative Disorder ◽  
Post Transplant ◽  
The Central Nervous System

scholarly journals Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy

Viruses ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 416
Author(s):  
Hiroaki Inoue ◽  
Shinya Rai ◽  
Hirokazu Tanaka ◽  
J. Luis Espinoza ◽  
Maiko Komori-Inoue ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Aplastic Anemia ◽  
Lymphoproliferative Disorder ◽  
Epstein Barr Virus ◽  
Hematopoietic Stem ◽  
Post Transplant ◽  
Barr Virus ◽  
The Central Nervous System ◽  
Epstein Barr

Aplastic anemia is a rare blood disease characterized by the destruction of the hematopoietic stem cells (HSC) in the bone marrow that, in the majority of cases, is caused by an autoimmune reaction. Patients with aplastic anemia are treated with immunosuppressive drugs and some of them, especially younger individuals with a donor available, can be successfully treated with hematopoietic stem cell transplantation (HSCT). We report here a rare case of post-transplant lymphoproliferative disorder (PTLD) associated with Epstein–Barr virus (EBV) reactivation in a 30-year-old female patient who underwent allogeneic HSCT for severe aplastic anemia. The PTLD, which was diagnosed 230 days after transplantation, was localized exclusively in the central nervous system (specifically in the choroid plexus) and manifested with obvious signs of intracranial hypertension. After receiving three cycles of high dose methotrexate (HD-MTX) combined with rituximab, the patient achieved a complete clinical recovery with normalization of blood cell counts, no evidence of EBV reactivation, and no associated neurotoxicity.

scholarly journals A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature

Oncotarget ◽  
2019 ◽  
Vol 10 (4) ◽  
pp. 437-448 ◽  
Author(s):  
Anju John John Velvet ◽  
Shiv Bhutani ◽  
Stavros Papachristos ◽  
Reena Dwivedi ◽  
Michael Picton ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Current Literature ◽  
Single Center ◽  
Post Transplant ◽  
Single Center Experience ◽  
The Central Nervous System
Sign in / Sign up

Export Citation Format

Share Document